Physician profile
Amit Varma
NPI 1477762425
$20,629.24
in general payments reported to CMS, 2019-2025
15 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,858 · 2020: $9,360 · 2021: $3,008 · 2022: $4,950 · 2023: $18.54 · 2024: $326 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17,091.73 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,585.13 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $197.87 | 2020-2024 | |
| Abiomed | $155.07 | 2021-2022 | |
| United Therapeutics Corporation | $141.80 | 2022-2024 | |
| Akcea Therapeutics, INC. | $124.99 | 2019 | |
| Esperion Therapeutics, INC. | $120.02 | 2021 | |
| Cvrx, INC. | $119.41 | 2021 | |
| Abbott Laboratories | $55.76 | 2023-2025 | Triclip, Cardiomems |
| Astrazeneca Pharmaceuticals Lp | $20.60 | 2021 | |
| Alnylam Pharmaceuticals INC. | $16.86 | 2024 | Onpattro |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.